H.I.G. Capital, a private equity firm, completed an investment in Rising Pharmaceuticals, a provider of generic and specialty pharmaceuticals. Financial terms were not disclosed. "We are excited to partner with Vimal Kavuru and Rising Pharmaceutical’s exceptional management team. As partners, we look forward to supporting Vimal and his team to further build upon Rising Pharmaceutical’s tremendous success. We see a major opportunity in the broader U.S. generic pharmaceutical industry, and the Company’s track record of identifying, developing and launching complex pharmaceutical products should create an exciting next chapter for Rising Pharmaceuticals," Mike Gallagher, H.I.G. Capital Managing Director.